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Abstract
Choline is an essential nutrient for humans, though some of the requirement can be met by
endogenous synthesis catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT).
Premenopausal women are relatively resistant to choline deficiency compared with postmenopausal
women and men. Studies in animals suggest that estrogen treatment can increase PEMT activity. In
this study we investigated whether the PEMT gene is regulated by estrogen. PEMT transcription was
increased in a dose-dependent manner when primary mouse and human hepatocytes were treated
with 17-β-estradiol for 24 h. This increased message was associated with an increase in protein
expression and enzyme activity. In addition, we report a region that contains a perfect estrogen
response element (ERE) ∼7.5 kb from the transcription start site corresponding to transcript variants
NM_007169 and NM-008819 of the human and murine PEMT genes, respectively, three imperfect
EREs in evolutionarily conserved regions and multiple imperfect EREs in nonconserved regions in
the putative promoter regions. We predict that both the mouse and human PEMT genes have three
unique transcription start sites, which are indicative of either multiple promoters and/or alternative
splicing. This study is the first to explore the underlying mechanism of why dietary requirements for
choline vary with estrogen status in humans.—Resseguie, M., Song, J., Niculescu, M. D., da Costa,
K., Randall, T. A., Zeisel, S. H. Phosphatidylethanolamine N-methyltransferase (PEMT) gene
expression is induced by estrogen in human and mouse primary hepatocytes.
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CHOLINE IS AN ESSENTIAL NUTRIENT (1); it is used to form cell membranes, it is the major source of methyl-
groups in the diet, and it is a precursor for biosynthesis of the neurotransmitter acetylcholine
(2). Choline is critical during fetal development, when it influences stem cell proliferation and
apoptosis, thereby altering brain structure and function (3–7). Similarly, it influences neural
tube development (8,9). In later life, choline deficiency causes fatty liver, liver damage, and
muscle damage (10,11). It also reduces the capacity to handle a methionine load, resulting in
elevated homocysteine (10), a risk factor for cardiovascular disease (12). Though many foods
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contain choline (13,14), there is at least 2-fold variation in dietary intake in humans (9,15).
Choline can also be derived from de novo biosynthesis of phosphatidylcholine catalyzed by
phosphatidylethanolamine N-methyltransferase (PEMT, EC 2.1.1.17) (16,17). Most of this
enzyme's activity is in the liver (18).
When fed a diet low in choline, premenopausal women were much less likely to develop
choline-deficiency associated organ dysfunction compared to men or postmenopausal women
(19). This suggests that premenopausal women might have an enhanced capacity for de novo
biosynthesis of choline. Such a finding would be important during pregnancy and lactation,
when the demand for choline is especially high because the transport of choline from mother
to infant, via placenta or mammary gland, constitutes an extraordinary drain on maternal
choline stores (20).
Studies in animal models support this hypothesis. Female rats are less sensitive to choline
deficiency than are male rats (21), and female mice produce more phosphatidylcholine via the
PEMT pathway than do male mice (22). Estrogen status may be important for this increased
PEMT activity; estradiol treatment increased PEMT activity in pituitary of rats (23) as well as
in liver of castrated-rats (24) and PEMT activity in liver was increased in diethylstilbestrol-
treated roosters (25). Thus, estrogen-mediated increases in PEMT activity in humans could be
an explanation for the lower dietary choline requirements of premenopausal women.
The mechanism whereby estrogen increases PEMT activity is not known. In the present study,
we report that there are motifs for estrogen response elements (EREs) in the promoter region
(s) of the PEMT gene.
MATERIALS AND METHODS
Materials
All reagents were obtained from Fisher Scientific (Fair Lawn, NJ, USA), unless otherwise
noted.
Animals
All animal procedures were approved by the University of North Carolina Institutional Animal
Care and Use Committee. Male C57BL/6J mice (5−7 wk old) were obtained from Jackson
Laboratories (Bar Harbor, ME, USA) and were housed individually in cages in a climate-
controlled room (24°C) exposed to a 12-hr light cycle, fed AIN76A semipurified diet (Dyets,
Bethlehem, PA, USA) and water ad libitum.
Primary mouse hepatocyte isolation
Mice were anesthetized (200 mg ketamine/kg and 16 mg xylazine/kg) by subcutaneous
injection, and the livers harvested. Hepatocytes were isolated from the livers by a modification
of the method described previously (26). Briefly, the liver was perfused, through a needle
aligned along the inferior vena cava, with buffer (pH 7.5) containing 137 mmol/L NaCl, 5.4
mmol/L KCl, 0.5 mmol/L NaH2PO4, 0.42 mmol/L Na2HPO4, 10 mmol/L HEPES, 0.5 mmol/
L EGTA, 4.2 mmol/L NaHCO3, and 5 mmol/L glucose; collagenase buffer, pH 7.5, contained
137 mmol/L NaCl, 5.4 mmol/L KCl, 5 mmol/L CaCl2, 0.5 mmol/L NaH2PO4, 0.42 mmol/L
Na2HPO4, 10 mmol/L HEPES, 0.15 g/L collagenase B (Boehringer Mannheim Corp,
Indianapolis, IN, USA), 0.05 g/L trypsin inhibitor, 4.2 mmol/L NaHCO3, and 0.016 mmol/L
phenol red. The collagenase-perfused liver was then dissected, suspended in Hanks' solution
(30 ml), and filtered through cheesecloth and a 100 μm nylon membrane to remove connective
tissue debris and cell clumps. Hepatocytes were subjected to centrifugation (42 g, 2 min at 4°
C) and resuspended in Hanks solution; this was repeated 4×. Then hepatocytes were purified
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using density gradient centrifugation (45% Percoll solution, 42 g for 10 min at 4°C). Cell
viability, measured by trypan blue exclusion, was more than 90%.
Preparation of estradiol-free serum for hepatocyte culture
Charcoal (Norit A, acid washed, Sigma-Aldrich, St. Louis, MO, USA) was washed twice with
cold sterile water immediately before use. A 5% charcoal–0.5% dextran T70 (Pharmacia-LKB,
Uppsala, Sweden) suspension was prepared, and aliquots were centrifuged at 1600 g for 10
min. Supernatants were aspirated, and fetal bovine serum (Biomeda, Foster City, CA, USA)
was mixed with the charcoal pellets. This charcoal-serum mixture was kept in suspension by
rolling at 4 cycles/min at 37°C for 1 h. After centrifugation at 1600 g for 20 min, the supernatant
was passed through a 0.45 μm filter (Nalgene, Rochester, NY, USA). The charcoal stripped
serum was then stored at −20°C until needed. More than 99% of serum sex steroids are reported
to be removed by this treatment (27).
Murine hepatocyte culture
Primary mouse hepatocytes were maintained in DMEM/F12 medium (GIBCO-Life
Technologies, Inc., Carlsbad, CA, USA), supplemented with 10% fetal bovine serum
(Biomeda) and antibiotics (100 U/ml penicillin and 100 μg/ml of streptomycin; Sigma-
Aldrich), at 37°C in humidified air containing 5% CO2. Briefly, 1.5 × 106 cells were seeded
onto 60 mm culture dishes (BD Biosciences, Franklin Lakes, NJ, USA), incubated in fresh
medium for 24 h and then washed with 1× phosphate buffered saline (PBS) twice before further
incubation in medium that contained 90% phenol red-free DMEM/F12 supplemented with 10%
charcoal stripped E2-free serum for 48 h. This medium was used to effect growth-factor
deprivation (28). Cells then were treated with 0−100 nmol/L 17-β-estradiol (E2; prepared and
stored in phenol red-free DMEM/F12 at 73 μmol/L per manufacturer's instructions; Sigma-
Aldrich). After 24 h incubation with E2, cells were harvested for total RNA; after 48 h
incubation with E2, cells were harvested for the microsomal protein fraction.
Murine Pemt relative real-time mRNA quantification
Total RNA was extracted from cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer's instructions. Primers and probes for murine Pemt and β-
actin were designed using JaMBW software (http://www.bioinformatics.org/JaMBW[b];
Table 1). The Pemt probe was labeled with a reporter dye (FAM, 6-carboxyfluorescein) at the
5′ end and a quencher dye (TAMRA, 6-carboxytetramethylrhodamine) at the 3′ end. The β-
actin probe was labeled with a reporter dye (TET, tetramethylrhodamine) at the 5′ end.
Quantitation of Pemt and β-actin mRNA levels was performed by a real-time RT-PCR assay
using an ABI prism 7700 sequence detection system (ABI, Foster City, CA, USA). A 30 μL
reaction mixture contained 500 ng of total RNA and 0.5 μmol/L of each primer. The reaction
conditions were designed as follows: reverse transcription (RT) at 48°C for 30 min and initial
denaturation at 95°C for 10 min followed by 40 cycles with 15 s at 95°C for denaturing and 1
min at 60°C for annealing and extension. Relative quantification of Pemt mRNA expression
was calculated by the comparative threshold (Ct) method described elsewhere (29). The
relative quantification value of the target gene, normalized to an endogenous control gene and
relative to a calibrator, was expressed as 2−ΔΔCt (Power/folds), where ΔCt = Ct of target gene
(Pemt) – Ct of endogenous control gene (β-actin), and ΔΔCt = ΔCt of samples for target gene
(estrogen treatment) - ΔCt of the calibrator (without estrogen treatment, negative control) for
the Pemt gene. Final results are expressed as mean ratio of Pemt gene expression for each
estrogen treatment normalized to Pemt gene expression without estrogen.
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Protein (50 μg) was separated by SDS-polyacrylamide gel electrophoresis on a 12.5%
polyacrylamide gel and transferred to a polyvinylidene difluoride membrane (Sigma-Aldrich),
which was probed with anti-PEMT antibody (a kind gift from Dr. Dennis E. Vance), washed
extensively, and then probed with horseradish peroxidase-conjugated goat anti-rabbit IgG
(Pierce, Rockford, IL, USA). PEMT protein was visualized by a reaction with Supersignal
chemiluminescent substrate (Pierce) and exposed to X-ray film (Denville Scientific, Metuchen,
NJ, USA).
Human hepaocyte isolation
Primary human liver cells were provided as a gift by Admet Technologies (Durham, NC, USA).
They used donated livers not suitable for orthotopic liver transplantation obtained from
federally designated organ procurement organizations. Informed consent was obtained from
next of kin for use of the livers for research purposes. Isolation of hepatocytes was performed
by members of the Admet Technologies research team as described previously (30). These
hepatocytes were transferred to us and used within 96 h of isolation.
Human hepatocyte culture
Cells were plated at a density of ∼1.8 × 106 cells per well on collagen-coated 6-well culture
plates (BD Biosciences) and incubated for 6 h at 37°C in humidified air containing 5% CO2
in William's complete medium E (WCME; GIBCO-Life Technologies, Inc.) containing 10%
Dextran-treated charcoal stripped fetal bovine serum (Biomeda) and antibiotics (100 U/ml
penicillin and 100 μg/ml streptomycin; Sigma-Aldrich). Medium was replaced at 6 h with
serum-free WCME. Following a 48 h “recovery period” in serum-free WCME, human primary
cells were incubated for 24 h in WCME with 0−1000 nmol/L 17-β-estradiol (prepared and
stored per manufacturer's instructions). After 24 h incubation with E2, cells were harvested for
cytoplasmic mRNA; after 48 h incubation with E2, cells were harvested for total cellular protein
fraction.
Human PEMT mRNA quantification
Cytoplasmic RNA from liver cells was extracted using the RNeasy mini kit (Qiagen, Valencia,
CA, USA). PCR primers for human PEMT, proteinase inhibitor-9 (PI-9; positive control) and
TATA-box binding protein (TBP; housekeeping gene) were designed using online Gene Fisher
interactive primer design software (http://bibiserv.techfak.uni-bielefeld.de/genefisher/; Table
1) and purchased from Operon (Germantown, MD, USA). Real-time PCR reactions were
performed using 100 ng RNA, 0.5 μmol of each primer, and the one-step QuantiTect SYBR
Green RT-PCR kit (Qiagen) in a 40 μl reaction. The reaction conditions were designed as
follows: RT at 50°C for 30 min and PCR initial activation step at 95°C for 15 min. Initial
denaturation at 94°C for 15 s was followed by 40 cycles of annealing (58°C for 30 s) and
extension (72°C for 30 s). Changes in PEMT mRNA levels were detected using an iCycler iQ
Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). Relative quantification of
PEMT mRNA expression was calculated by the Ct method as described earlier, and final results
were expressed as a ratio change relative to untreated and normalized for TBP mRNA
expression. We used expression of the PI-9 gene, known to be estrogen responsive (31), as a
positive control (data not shown).
PEMT protein expression and activity assay
Mouse and human hepatocytes were harvested 48 h after 17-β-estradiol treatment with two
washes of 1× PBS, scraped into medium 1 (250 mmol/L sucrose, 10 mmol/L Tris, pH 7.4, 1
mmol/L EDTA, and 1 mmol/L dithiothreitol) and homogenized with 10 complete strokes in a
Teflon™-glass homogenizing vessel. For the murine cellular homogenate, an aliquot of total
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cellular homogenate was then centrifuged at 100,000 g for 1 h to obtain total particulate
(membrane) fraction. Total murine particulate protein (50 μg) was used for PEMT activity
assays as described previously using phosphatidyldimethylethanolamine (PDME; Avanti Polar
Lipids, Alabaster, AL, USA) as the methyl acceptor and S-adenosyl-L-[methyl-3H] methionine
(American Radiolabeled Chemicals Inc., St. Louis, MO, USA) as the methyl group donor
(32).
Comparative bioinformatics promoter analysis
CAGE analysis—CAGE analysis (cap analysis gene expression) data were retrieved from
the FANTOM3 website (http://fantom.gsc.riken.go.jp/). CAGE analysis (33) was used to
identify the major transcription start sites (TSS) for the mouse and human PEMT gene.
EST abundance of various PEMT transcripts—The positions of expressed sequence
tag (EST) sequences from the NCBI dbEST (http://www.ncbi.nlm.nih.gov/dbEST/; last
accessed on 01/03/07) were displayed relative to the mouse and human PEMT gene of the
Mouse and Human genome (May 2004 release) using the GenomBench tool of Vector NTI
10.1 (Invitrogen). All potentially full-length ESTs were selected and found to group into three
clusters, differing in the 5′ start of the ESTs for both human and mouse.
Identification of evolutionarily conserved regions (ECRs) and conserved
transcription factor binding sites—The analysis of human and mouse syntenic
relationships and conservation profiles was done through the annotation of ECRs in the
alignments of genomes. We used the BLASTZ-based genome alignments generated by the
ECR Browser (http://ecrbrowser.dcode.org; last accessed 01/03/07) (34). A genomic interval
was annotated as an ECR if it was >100 bp and >70% identity as defined by the number of
nucleotide matches in a sliding window (default settings). Prediction of potential conserved
transcriptional binding sites was then done using the rVista 2.0 search tool within the ECR
Browser. The Transfac V10.2 database was used to scan these ECRs using default settings.
Estrogen response element identification—EREs were identified with detection
parameters set on the basis of optimized settings for the Dragon ERE Finder
(http://sdmc.lit.org.sg/ERE-V2/index; last accessed 01/03/07) using the default 83%
sensitivity (35). Conserved EREs were identified as elements present in both the human and
mouse PEMT gene at distances comprised between −10 to + 15 kb from their respective
transcription start sites (TSS A, TSS B, TSS C).
Data analysis—Prior to analysis, all data were normalized to the 0 nmol/L estrogen treatment
for each individual (mouse and human). Data were expressed as mean ratio change of each
estrogen treatment vs. no treatment ± SE. Ratios were transformed to a log(2) scale to ensure
normal distribution of the data, required by the parametric testing assumptions. Protein
expression and gene expression significance of change statistical differences were assessed by
one-way analysis of variance (ANOVA) followed by the Tukey-Kramer (P<0.05) multiple
comparison test (JMP Version 3.2, SAS Institute Inc, Cary, NC, USA). Logistic regression
analysis was performed to assess the trend significance of the dose response to estrogen (JMP
Version 3.2), using ratio values. Linear Fit was used to determine the correlation between
PEMT gene expression and activity, using only the points that have both gene expression and
activity data.
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Estrogen up-regulates murine Pemt gene expression, protein levels and enzyme activity
In mouse hepatocytes gene expression, protein expression and activity all were significantly
increased by 17-β-estradiol treatment (Fig. 1), and a strong dose-response relationship was
found for both activity (EC50 = 1 nmol/L; P<0.0001) and gene expression (EC50=5 nmol/L;
P<0.0001). Additionally, a strong correlation was found between gene expression and activity
(correlation coefficient=0.91).
Estrogen up-regulates human PEMT gene expression and enzyme activity
In human hepatocytes, gene expression and activity were significantly increased by 17-β-
estradiol treatment (Fig. 2) and a strong dose-response relationship was found for both activity
(EC50=1 nmol/L; P<0.0006) and gene expression (EC50=10 nmol/L; P<0.0001) using logistic
regression analysis. Gene expression and activity further increased at 1000 nmol/L estrogen
treatment (data not shown). However, a linear fit model suggests that there is only a weak
correlation between PEMT gene expression and activity (0.34) correlation coefficient.
Characterization of the major human and mouse PEMT transcripts
The human PEMT gene, which is located on chromosome 17p11.2, has 9 exons and 8 introns
spanning its 86 kb length, and it encodes three variant transcripts
(
http://www.ensembl.org/Homo_sapiens/geneview?gene=OTTHUMG00000059290;db=vega
, date last accessed 1/02/07). Each of the three transcript variants has only 7 exons and 6 introns
due to splicing of the leading exons 1−3, which are alternatively spliced to a common exon 4,
where translation begins (36). Three RefSeq accessions have been annotated for the human
PEMT gene by NCBI, NM_148172, NM_007169, and NM_148173. Murine Pemt, located on
chromosome 11, has been reported to have 7 exons and 6 introns spanning ∼75 kb and encoding
one major transcript, annotated by NCBI RefSeq accession NM_008819.
(
http://www.ensembl.org/Mus_musculus/geneview?gene=OTTMUSG00000005808;db=vega
, date last accessed 1/02/07) (37). Primer extension analysis of the murine Pemt gene
demonstrated experimentally that the major Pemt TSS is located 139 bp upstream of the
initiator methionine codon (37). Human and murine PEMT proteins are 80% homologous, but
unlike its human counterpart, murine PEMT protein translation initiation begins in exon 2. It
was previously reported that the transcript that begins with exon 2 [NM_007169] is the most
abundant in human liver and that only one transcript [NM_008819] exists for the mouse
Pemt gene (36,37).
To more fully characterize the various alternative TSS in the human and mouse PEMT
orthologs, we estimated the relative abundance of the major PEMT transcripts in human and
mouse liver based on the ESTs in dbEST and used FANTOM3 CAGE analysis viewer to
determine the location of the various TSS (Fig. 3). Using publicly available data from dbEST,
we found that the vast majority of the 5′ ends of the ESTs cluster around the start point of
NM_148172 (bp 17,435,719 of ch. 17) (denoted as human TSS A), suggesting that this is the
most abundant transcript in the liver for the human PEMT gene. This TSS is independently
confirmed by the results of the FANTOM CAGE analysis where the representative CAGE TSS
for the PEMT gene is at bp 17,435,731, 12 bp upstream of the RefSeq defined start. For
NM_007169 (start defined at bp 17,426,470) (denoted as human TSS B), a representative
CAGE TSS is found 40 bp upstream at bp 17,426,510. For NM_148173 (start defined at bp
17,421,504) (denoted as human TSS C), a representative CAGE start is found at bp 17,421,107
while the start based on the average of ESTs is 17,421,043; both are several hundred basepairs
downstream of the RefSeq defined start.
Resseguie et al. Page 6













We also suggest that the mouse Pemt gene has two previously unreported transcripts (denoted
murine transcripts A and C) in addition to the previously described transcript, NM_008819
(denoted murine transcript B), which is also the most abundant transcript based on the
abundance of ESTs in dbEST. The majority of the 5′ ends of the available ESTs (the EST
average start; 59,649,465) cluster around the start point of NM_008819 (bp 59,649,379 of ch.
11) (denoted murine TSS B), while CAGE analysis predicts the representative TSS at bp
59,649,447, which is 68 bp upstream of the RefSeq defined start for NM_008819. Available
EST data suggest two additional mouse transcripts, transcript A, initiating ∼9 kp upstream of
NM_008819; and transcript C, initiating ∼5 kb downstream. A representative CAGE TSS for
transcript A is at 59,659,083, denoted murine TSS A, while the EST average start suggests a
start at 59,658,975, within 108 bp of the CAGE start. For transcript C a representative CAGE
TSS is at 59,644,334, denoted murine TSS C, and with the EST average start position is
59,644,300. Thus, based on both EST sequences from dbEST and from CAGE analysis from
the FANTOM3 database we conclude that both the mouse and human PEMT genes have three
unique transcription start sites that are indicative of multiple promoters. While the
identification of two additional transcripts in the mouse gene suggests conserved transcriptional
regulation between species, it is interesting to speculate why transcript variant B (NM_008819)
is the more abundant transcript in mice, whereas transcript variant A (NM_148173) is more
abundant in humans.
Initial analysis of the human PEMT putative promoter B sequence for the exon-2 containing
transcript, NM_007169, suggested that it contained transcription factor binding sites critical
for SREBP and C/EBP; however, promoter B lacks core promoter elements such as a TATA
or CCAAT boxes (36). We report that the region upstream of putative promoter A, exon-1
containing and the most abundant transcript variant NM_148172, contains a CpG island as
well as core promoter elements including an experimentally validated 600 bp RNA polymerase
II binding site (Pol 9419, P<0.00001) (Fig. 3,Table 2) (38).
Identification of an evolutionarily shared promoter framework in the PEMT gene
In orthologous promoters, elements important for transcriptional regulation may be expected
to be conserved during evolution (39). Evolutionarily conserved regions (ECRs) were
identified from two species (Homo sapiens and Mus musculus) in the PEMT promoter(s) by
using the comparative genomics tool ECR Browser (as described in Experimental Procedures).
We determined that the PEMT gene promoters contain six evolutionarily conserved regions
within the region encompassing the three TSS predicted for the PEMT gene in each species
(Fig. 3, Table 2). The region containing this cluster of ECRs is ∼18 kb for each organism with
ECR 6 overlapping the TSS of the shortest predicted transcript for each and ECR 1 being 4 kb
upstream of NM_148172 (human) and 9.7 kb of transcript A (mouse). No other ECRs were
found in the 15 kb upstream of ECR 1 in the mouse or within 29 kb of the human ECR 1.
Within these conserved regions, predicted transcription factor binding sites are likely to be
conserved (Table 2).
EREs previously identified in human genes often have counterparts at similar positions in their
mouse orthologs. Because conservation of newly identified EREs between the two species may
indicate a functional role of these elements, we searched for the presence of conserved EREs
with less than 9 kb difference in distance from their respective transcriptional start sites. For
estrogen binding-site predictions we used the previously described ERE model (35) and AP1
and SP1 binding-site position weight matrices from the TRANSFAC database (40). We
identified one perfect consensus estrogen response element ∼7.5 kb from transcription start
site B, TSS (+1), in both the human and murine PEMT promoters. In the murine Pemt gene
promoter region we identified seven imperfect EREs differing from the consensus by 1−3
nucleotides, three of which are located in ECRs in close proximity to TSS B and TSS C (Fig.
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3, Table 2). The human PEMT promoter region contains eight imperfect estrogen response
motifs, three of which occur in an evolutionarily conserved region in close proximity to
Promoter B (TSS B) and Promoter C (TSS C) (Fig. 3, Table 2). We also found several AP1,
SP1 and FOXA1 sites in these evolutionarily conserved regions.
DISCUSSION
Choline is derived not only from the diet, but as well from de novo synthesis of
phosphatidylcholine catalyzed by PEMT (2). We have previously reported that when deprived
of dietary choline, men and postmenopausal women are more likely to develop fatty liver or
muscle damage compared to premenopausal women (19). In the present study, we observed
that estrogen, at doses bracketing physiological concentrations in humans (0−100 nmol/L),
caused a marked up-regulation in PEMT mRNA expression and enzyme activity, and that the
PEMT gene has motifs (41) that may act as EREs in its promoter regions. This observation
may help to explain why premenopausal women usually do not develop organ dysfunction
when fed a diet low in choline (19); they have estrogen-induced increased capacity for
endogenous biosynthesis of the choline moiety.
Pregnancy and lactation are times when demand for choline is especially high. Indeed, transport
of choline from mother to fetus (42,43) depletes maternal plasma choline in humans (44). Thus,
despite an apparent enhanced capacity to synthesize choline, the demand for this nutrient is so
high that stores are depleted (20). Because milk contains a great deal of choline, lactation further
increases maternal demand for choline, resulting in further depletion of tissue stores (20,45).
Pemt −/− mice abort pregnancies around 9−10 days gestation unless fed supplemental choline
(personal observation). Women in the United States vary enough in dietary choline intake (from
<300 mg/d to >500 mg/d) to influence the risk that they will have a baby with a birth defect;
low dietary intake of choline during pregnancy was associated with a 4-fold increased risk of
giving birth to an infant with a NTD (9) and 1.5-fold increased risk for orofacial clefts (46).
Choline nutriture during pregnancy is especially important because it influences brain
development in the fetus (3–5,47–56). These observations suggest that women depend on high
rates of endogenous biosynthesis of choline induced by estrogen, as well as on dietary intake
of choline to sustain normal pregnancy. It is biologically plausible that, during evolution,
appropriate mechanisms were developed to ensure that young women are less susceptible to
dietary choline deficiency and have adequate stores of choline prior to, and during pregnancy.
Our observation that PEMT gene expression in mice and humans is induced by physiological
concentrations of estrogen in humans (0−100 nmol/L) (57) correlates with the previous finding
that estrogen increases PEMT activity in liver of the bird (25,58,59), the rat liver (24), and the
rat pituitary (23,60). The classic actions of estrogen occur through its receptors ERα and
ERβ, which bind as homodimers or heterodimers to EREs in the promoters of many estrogen-
responsive genes (41). The consensus ERE (PuGGTCAnnnTGACCPy) is an inverted
palindromic sequence separated by three intervening nucleotides (41). This motif is usually
surrounded by 50 nucleotide-flanking regions that contain other transcription factor binding
sites (61). Imperfect ERE half-site motifs (ERE1/2) also bind with ERα and ERβ (62–64). It
is noteworthy that the majority of known estrogen responsive genes contain imperfect EREs
that differ from the consensus sequence (65). EREs are usually found within −10 to + 5 kb of
transcriptional start sites, and ∼1% of elements appear to be conserved in the flanking regions
of orthologous human and mouse genes (66). Functional evolutionarily conserved EREs are
most abundant in the 0 to + 1 kb region around transcriptional start sites (66). Estrogen also
can mediate its effect on proximal gene promoters from distances up to 10 kb by acting as an
enhancer element (66). This seems to be especially true when estrogen response motifs are
located in the proximal gene region. EREs that are located far away from the promoter of a
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single gene can interact synergistically with EREs in the proximal promoter by DNA looping
(67).
In mice, we found three conserved EREs at position + 790 bp and + 813 bp downstream of the
TSS B and + 66 bp upstream of TSS C. In humans, we found three conserved EREs at positions
+ 725 bp and + 741 bp downstream of TSS B and + 466 bp of TSS C (Table 2). One of the
ERE1/2 we found was embedded in an Alu repeat sequence. Alu elements, the most abundant
interspersed repeats in the human genome, have repeatedly been found to be involved in gene
rearrangements in humans (68). Ubiquitous presence of Alu repeats and their specific
properties suggest a number of functions for the Alu elements, one of which is the introduction
of functional estrogen response elements into gene promoters (68). Finally, not all genes that
are regulated by estrogen contain an ERE. Estrogen may regulate these target genes through
interactions with other transcription factors such as activator protein 1, AP1 (25,58,59), NF-
κB (60), or specific factor, Sp1 (41), and FOXA1 (69,70). We found several AP1, FOXA1,
and SP1 sites in both conserved and nonconserved promoter regions.
It was previously reported that the murine Pemt gene encodes one major transcript and that
transcription was initiated from a single promoter (37). Both EST and CAGE analysis suggests
the existence of three transcripts for the murine Pemt gene and for its human ortholog. A cluster
of ECRs within the putative promoter region contains the multiple TSS for each species and
many conserved predicted binding sites for transcription factors within these ECRs and
throughout the sequence analyzed above. Based on multiple similarities in gene and protein
structure, it is reasonable to predict that the murine and human PEMT genes are regulated in
a similar manner.
This report is the first to identify a possible mechanism through which estrogen induces
PEMT expression and may explain the observation that premenopausal women are relatively
resistant to choline deficiency. Future studies may include measuring the abundance of the
three PEMT gene transcripts in human and murine hepatocytes cultured in the presence and
absence of 17-β-estradiol in order to determine whether estrogen treatment causes alternative
promoter use and/or splicing. We are currently determining whether recently identified single
nucleotide polymorphisms that increase women's dietary requirement for choline (71) work
by altering estrogen-mediated induction of the PEMT gene.
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Estrogen induces Pemt gene and protein expression and increases enzyme activity in primary
cultured mouse hepatocytes. Primary mouse hepatocytes were incubated with 17-β-estradiol
(0−100 nmol/L) for 24 h before harvesting. A) Detection of Pemt and β-actin mRNA levels
was performed by a real-time RT-PCR assay. Relative quantification of Pemt mRNA
expression was calculated by the comparative threshold cycle (Ct) method as described in
Experimental Procedures. Results are expressed as mean ratio change in gene expression ±
SEM. (n=3/point). *P < 0.05 different from no treatment. B) Total particulate protein was isolated
and analyzed for PEMT protein expression by Western blotting as described in Experimental
Procedures. Equal protein loading of lanes was assessed by Coomasie Blue gel staining (data
not shown). C) PEMT enzyme activity was assayed by a radio-enzymatic assay as described
in Experimental Procedures. Results are expressed relative to no treatment as mean ratio change
± SEM (n=3/point). *P < 0.05 different from no treatment.
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Estrogen induces PEMT gene expression and increases enzyme activity in primary cultured
human hepatocytes. Primary human hepatocytes from various donors were incubated with 17-
β estradiol (0−100 nmol/L) for 24 h before harvesting. A) Detection of PEMT and TATA-box
binding protein (TBP) mRNA levels was performed by a real-time RT-PCR assay. Relative
quantification of PEMT mRNA expression was calculated by the comparative threshold cycle
(Ct) method described in Experimental Procedures. Results are expressed as ratio fold change
in gene expression relative to untreated samples ± sem. (n=4−5/point). B) PEMT enzyme
activity was assayed by a radio-enzymatic assay as described in Experimental Procedures.
Results are expressed as ratio of change in enzyme activity (pmol/mg protein/min) relative to
untreated samples ± sem. (n=4−7/point). *P < 0.05 different from no treatment.
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Comparative analysis of murine and human PEMT gene promoters. A) 500 kbp alignment of
conserved syntenic blocks of human chromo-some 17 and mouse chromosome 11, with blue
boxes showing the relationships between orthologous genes. B) A 20 kbp enlargement of the
human PEMT gene encoded on the minus strand, the promoter region, and the mouse
orthologous region. The PEMT gene promoter region of the human and mouse contains six
distinct evolutionarily conserved regions (ECR 1-ECR 6). ECR 4 in murine Pemt has been
translocated to a different chromosome (data not shown). Three conserved estrogen response
elements are within ECR 5 and 6, shown as dark blue boxes; a perfect consensus ERE in a
distal promoter/enhancer region ∼7.5 kb from transcription start site (TSS) B is shown as
hatched blue boxes with red outline. Block arrow bars displayed beneath PEMT gene promoter
regions represent the major transcripts relative to TSS A, B, C, (indicated by yellow-green
arrows) with the percentages reflecting the EST abundance of each transcript in liver (purple
arrows indicate minor transcripts; red indicates the major transcript. Beneath the transcript
arrow bars is shown a representative CAGE analysis for the major human and mouse TSS. The
highest peak, shown in red, represents the predominant TSS for the PEMT gene. Lower peaks
around the major TSS (s) would represent some variation in the actual in vivo TSS.
Resseguie et al. Page 16




























































































































































































































































































































































































































































































































































































































































































































































Resseguie et al. Page 18
TABLE 2
Human and mouse conserved promoter motifs
Human Transcript Evolutionarily Conserved Region Motifs1 Position Sequence
ECR 1 PPARA −13233 TGATCT
[−13399−−13206] SP1 −13118 CCACAGCCCC
ERE −11388 TT-GGTCA-GGC-TGGTC-
TT
ECR 2 MYB −10839 GGCCAGTTC





ECR 3 CpG island −8774 CpG Repeat
[−9246−−9038] Exon 1 −9151











ECR 4 MYB −3264 AAACTGCCA





Transcript B: NM_007169 TSS+1 +1 TTGTCCATG (bp
17,426,514)
TSS B +40 GACCACAA (bp
17,426,470)
ECR 5 Exon 2 +50






Transcript C: NM_148173 ECR 6 TSS C +5010 TGTGGGCGA (bp
17,421,504)
[+5192−+5579] GATA +5284 TTTTATCTTC
ERE +5476 TG-GGCTA-CGT-GGACC-
CC
Mouse Evolutionarily Conserved Region Motifs1 Position Sequence
ECR 1 Ppar-α −12980 AGATCA
[−12997−−12808] Sp1 −12884 CCCACC
ECR 2 Ppar-α −11788 AGGTCA
[−11874−−11709 TSS A −9602 CATCAGATA (bp
59,659,083)
ECR 3 CpG island −9622
−−9169
CpG repeats
[−9592−−9382] ERE −7919 TA-GGTCA-GGA-
TGACC-TT
Consensus
    Transcript A
ECR 5 TSS B (+1) +1 CCCAGTGTG (bp
59,649,481)
(−190−+884)
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(+4848−+5243) Gata +5441 CTTTTATCTTC










For both human and mouse PEMT genes motif chromosomal position is displayed relative to transcription start site B (+1) based on the literature defined
major TSS for each (36,37); +/− indicates upstream or downstream orientation, respectively. For the human +1 site, this corresponds to bp 17,426,514 of
ch17. For mouse this corresponds to bp 59,649,481 on ch11 (UCSC May 2004 Release of the Mus musculus genome, mm5), which corresponds to bp
59,853,136 in the current release of the M. musculus genome (mm8). The mouse and human PEMT gene promoters are highly conserved in six distinct
evolutionarily conserved regions (ECR 1-ECR 6). ECR 4 in mouse Pemt has been translocated to a different chromosome (data not shown). There are
conserved estrogen response elements and transcription factor binding sites within ECR 5 and 6 in mouse and human proximal promoter regions. The
human and murine PEMT gene contains additional EREs, including a consensus ERE in a distal promoter/enhancer region approximately 7.5kb from TSS
B. The human promoter A region contains a CpG island and an experimentally validated 600 bp RNA polymerase II binding site (Pol 9419, P<0.00001)
(Figure 3, Table 2) (38). ECR browser, rVista TFBS search engine, Dragon ERE Finder, and TRANSFAC were used to identify ECRs, EREs, and TFBS,
respectively. Underline indicates nucleotides that differ from the estrogen response element consensus sequence. Italicized letters indicate transcription
start sites for each proximal promoter region denoted A, B, C.
1
Motif Abbrevations for gene names are from LocusLink (www.ncbi.nlm.nih.gov/LocustLink/list.cgi; last accessed 01/02/07).
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